Edward M. Kaye

Board Member

CEO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

STOK

Current role

Board Member, CEO

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Stoke Therapeutics, Inc. (STOK)	Former Chief Executive Officer	$148,726	—	$1,199,520	$1,298,138	—	$587,658	$3,234,043
2024	Stoke Therapeutics, Inc. (STOK)	Chief Executive Officer	$650,923	—	$2,975,700	$1,614,740	$358,008	$12,749	$5,612,120
2023	Stoke Therapeutics, Inc. (STOK)	Chief Executive Officer	$625,887	—	$1,299,300	$1,285,008	$309,814	$13,201	$3,533,210
2022	Stoke Therapeutics, Inc. (STOK)	M.D . Chief Executive Officer	$596,083	$32,293	—	$4,817,310	$290,636	$12,200	$5,748,522
2021	Stoke Therapeutics, Inc. (STOK)	Chief Executive Officer	$567,698	$15,612	—	$7,604,990	$343,458	$11,600	$8,543,358

No earnings-call appearances or filed executive changes recorded yet.